Skip to content

144Accepted Jan 11, 5:33 PM ET

EyePoint Pharmaceuticals, Inc. 144

Ocumension Therapeutics

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

5:33 PM

Jan 11, 2024

Filed

Jan 11, 2024

Documents

1

Size

5.6 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.